Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells.

Hutt-Fletcher LM.

J Virol. 2016 Dec 16;91(1). pii: e01677-16. doi: 10.1128/JVI.01677-16. Print 2017 Jan 1. Review.

2.

Braving the New World.

Hutt-Fletcher LM.

PLoS Pathog. 2016 Apr 28;12(4):e1005417. doi: 10.1371/journal.ppat.1005417. eCollection 2016 Apr. No abstract available.

3.

The Epstein-Barr Virus Glycoprotein gp150 Forms an Immune-Evasive Glycan Shield at the Surface of Infected Cells.

Gram AM, Oosenbrug T, Lindenbergh MF, Büll C, Comvalius A, Dickson KJ, Wiegant J, Vrolijk H, Lebbink RJ, Wolterbeek R, Adema GJ, Griffioen M, Heemskerk MH, Tscharke DC, Hutt-Fletcher LM, Wiertz EJ, Hoeben RC, Ressing ME.

PLoS Pathog. 2016 Apr 14;12(4):e1005550. doi: 10.1371/journal.ppat.1005550. eCollection 2016 Apr.

4.
5.

EBV glycoproteins: where are we now?

Hutt-Fletcher LM.

Future Virol. 2015;10(10):1155-1162.

6.

Epstein-Barr virus glycoprotein gM can interact with the cellular protein p32 and knockdown of p32 impairs virus.

Changotra H, Turk SM, Artigues A, Thakur N, Gore M, Muggeridge MI, Hutt-Fletcher LM.

Virology. 2016 Feb;489:223-32. doi: 10.1016/j.virol.2015.12.019. Epub 2016 Jan 13.

7.

Alcelaphine herpesvirus 1 glycoprotein B: recombinant expression and antibody recognition.

Dry I, Todd H, Deane D, Percival A, Mclean K, Inglis NF, Manson ED, Haig DM, Nayuni S, Hutt-Fletcher LM, Grant DM, Bartley K, Stewart JP, Russell GC.

Arch Virol. 2016 Mar;161(3):613-9. doi: 10.1007/s00705-015-2701-y. Epub 2015 Dec 9.

8.

Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.

Nawandar DM, Wang A, Makielski K, Lee D, Ma S, Barlow E, Reusch J, Jiang R, Wille CK, Greenspan D, Greenspan JS, Mertz JE, Hutt-Fletcher L, Johannsen EC, Lambert PF, Kenney SC.

PLoS Pathog. 2015 Oct 2;11(10):e1005195. doi: 10.1371/journal.ppat.1005195. eCollection 2015 Oct.

9.

Viral Entry.

Chesnokova LS, Jiang R, Hutt-Fletcher LM.

Curr Top Microbiol Immunol. 2015;391:221-35. doi: 10.1007/978-3-319-22834-1_7. Review.

PMID:
26428376
10.

Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells.

Xiong D, Du Y, Wang HB, Zhao B, Zhang H, Li Y, Hu LJ, Cao JY, Zhong Q, Liu WL, Li MZ, Zhu XF, Tsao SW, Hutt-Fletcher LM, Song E, Zeng YX, Kieff E, Zeng MS.

Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11036-41. doi: 10.1073/pnas.1513359112. Epub 2015 Aug 19.

11.

Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells.

Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, Du H, Li MZ, Huang WL, Tsao SW, Hutt-Fletcher L, Zeng YX, Kieff E, Zeng MS.

Nat Commun. 2015 Feb 11;6:6240. doi: 10.1038/ncomms7240.

12.

Epstein-Barr virus replicating in epithelial cells.

Hutt-Fletcher LM.

Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16242-3. doi: 10.1073/pnas.1418974111. Epub 2014 Nov 10. No abstract available.

13.

Epstein-Barr virus infection mechanisms.

Chesnokova LS, Hutt-Fletcher LM.

Chin J Cancer. 2014 Nov;33(11):545-8. doi: 10.5732/cjc.014.10168. Epub 2014 Oct 17. Review.

14.

Epstein-Barr virus glycoprotein gB and gHgL can mediate fusion and entry in trans, and heat can act as a partial surrogate for gHgL and trigger a conformational change in gB.

Chesnokova LS, Ahuja MK, Hutt-Fletcher LM.

J Virol. 2014 Nov;88(21):12193-201. doi: 10.1128/JVI.01597-14. Epub 2014 Aug 20.

15.

Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.

Jiang R, Ekshyyan O, Moore-Medlin T, Rong X, Nathan S, Gu X, Abreo F, Rosenthal EL, Shi M, Guidry JT, Scott RS, Hutt-Fletcher LM, Nathan CA.

J Oral Pathol Med. 2015 Jan;44(1):28-36. doi: 10.1111/jop.12221. Epub 2014 Jul 18.

16.

αvβ6- and αvβ8-integrins serve as interchangeable receptors for HSV gH/gL to promote endocytosis and activation of membrane fusion.

Gianni T, Salvioli S, Chesnokova LS, Hutt-Fletcher LM, Campadelli-Fiume G.

PLoS Pathog. 2013;9(12):e1003806. doi: 10.1371/journal.ppat.1003806. Epub 2013 Dec 19.

17.

αvβ3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.

Gianni T, Leoni V, Chesnokova LS, Hutt-Fletcher LM, Campadelli-Fiume G.

Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19792-7. doi: 10.1073/pnas.1212597109. Epub 2012 Nov 12.

18.

Oral dysplasia and squamous cell carcinoma: correlation between increased expression of CD21, Epstein-Barr virus and CK19.

Jiang R, Gu X, Moore-Medlin TN, Nathan CA, Hutt-Fletcher LM.

Oral Oncol. 2012 Sep;48(9):836-41. doi: 10.1016/j.oraloncology.2012.03.017. Epub 2012 Apr 16.

19.

Important but differential roles for actin in trafficking of Epstein-Barr virus in B cells and epithelial cells.

Valencia SM, Hutt-Fletcher LM.

J Virol. 2012 Jan;86(1):2-10. doi: 10.1128/JVI.05883-11. Epub 2011 Oct 26.

20.
21.

Laser capture microdissection for analysis of gene expression in formalin-fixed paraffin-embedded tissue.

Jiang R, Scott RS, Hutt-Fletcher LM.

Methods Mol Biol. 2011;755:77-84. doi: 10.1007/978-1-61779-163-5_6.

PMID:
21761295
22.

Gammaherpesviruses entry and early events during infection.

Chandran B, Hutt-Fletcher L.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 23.

23.

Integrins as triggers of Epstein-Barr virus fusion and epithelial cell infection.

Hutt-Fletcher LM, Chesnokova LS.

Virulence. 2010 Sep-Oct;1(5):395-8. doi: 10.4161/viru.1.5.12546. Review.

24.

Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8.

Chesnokova LS, Nishimura SL, Hutt-Fletcher LM.

Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20464-9. doi: 10.1073/pnas.0907508106. Epub 2009 Nov 17. Erratum in: Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3275.

25.

The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein.

Gore M, Hutt-Fletcher LM.

Virology. 2009 Jan 5;383(1):162-7. doi: 10.1016/j.virol.2008.10.010. Epub 2008 Nov 7.

26.

Epstein-Barr virus LF2: an antagonist to type I interferon.

Wu L, Fossum E, Joo CH, Inn KS, Shin YC, Johannsen E, Hutt-Fletcher LM, Hass J, Jung JU.

J Virol. 2009 Jan;83(2):1140-6. doi: 10.1128/JVI.00602-08. Epub 2008 Nov 5.

27.

Laser-capture microdissection of oropharyngeal epithelium indicates restriction of Epstein-Barr virus receptor/CD21 mRNA to tonsil epithelial cells.

Jiang R, Gu X, Nathan CO, Hutt-Fletcher L.

J Oral Pathol Med. 2008 Nov;37(10):626-33. doi: 10.1111/j.1600-0714.2008.00681.x. Epub 2008 Aug 15.

28.
29.

Epstein-Barr virus entry.

Hutt-Fletcher LM.

J Virol. 2007 Aug;81(15):7825-32. Epub 2007 Apr 25. Review. No abstract available.

30.

Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion.

Wu L, Hutt-Fletcher LM.

Virology. 2007 Jun 20;363(1):148-55. Epub 2007 Feb 20.

31.

Antibodies to gp350/220 enhance the ability of Epstein-Barr virus to infect epithelial cells.

Turk SM, Jiang R, Chesnokova LS, Hutt-Fletcher LM.

J Virol. 2006 Oct;80(19):9628-33.

32.

Epstein-Barr virus shed in saliva is high in B-cell-tropic glycoprotein gp42.

Jiang R, Scott RS, Hutt-Fletcher LM.

J Virol. 2006 Jul;80(14):7281-3.

33.

Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, Hayward GS, Hayward SD.

J Virol. 2006 Feb;80(3):1098-109.

34.
35.

Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA.

Chang H, Gwack Y, Kingston D, Souvlis J, Liang X, Means RE, Cesarman E, Hutt-Fletcher L, Jung JU.

J Virol. 2005 Apr;79(8):4651-63.

36.

Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts.

Chen H, Huang J, Wu FY, Liao G, Hutt-Fletcher L, Hayward SD.

J Virol. 2005 Feb;79(3):1724-33.

37.

Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion.

Ressing ME, van Leeuwen D, Verreck FA, Keating S, Gomez R, Franken KL, Ottenhoff TH, Spriggs M, Schumacher TN, Hutt-Fletcher LM, Rowe M, Wiertz EJ.

J Virol. 2005 Jan;79(2):841-52.

38.

Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication.

Guerreiro-Cacais AO, Li L, Donati D, Bejarano MT, Morgan A, Masucci MG, Hutt-Fletcher L, Levitsky V.

J Gen Virol. 2004 Oct;85(Pt 10):2767-78.

PMID:
15448337
39.

Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection.

Borza CM, Morgan AJ, Turk SM, Hutt-Fletcher LM.

J Virol. 2004 May;78(10):5007-14.

40.
41.

Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.

Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD.

J Virol. 2003 Dec;77(24):13267-74.

42.

Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.

Ressing ME, van Leeuwen D, Verreck FA, Gomez R, Heemskerk B, Toebes M, Mullen MM, Jardetzky TS, Longnecker R, Schilham MW, Ottenhoff TH, Neefjes J, Schumacher TN, Hutt-Fletcher LM, Wiertz EJ.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11583-8. Epub 2003 Sep 22.

43.
44.
46.

Two Epstein-Barr virus glycoprotein complexes.

Hutt-Fletcher LM, Lake CM.

Curr Top Microbiol Immunol. 2001;258:51-64. Review. No abstract available.

PMID:
11443867
47.

EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma.

Ruf IK, Rhyne PW, Yang H, Borza CM, Hutt-Fletcher LM, Cleveland JL, Sample JT.

Curr Top Microbiol Immunol. 2001;258:153-60. Review. No abstract available.

PMID:
11443860
48.

Biosynthetic radiolabeling of virus glycoproteins for immunoprecipitation and electrophoretic analysis.

Hutt-Fletcher LM, Turk SM.

Methods Mol Biol. 2001;174:243-6. No abstract available.

PMID:
11357651
49.

Virus isolation.

Hutt-Fletcher LM, Turk SM.

Methods Mol Biol. 2001;174:119-23. No abstract available.

PMID:
11357633
50.

Supplemental Content

Loading ...
Support Center